Fig. 4: Global map showing the regional pooled prevalence of mpox vaccine uptake across five population groups (overall, PLHIV, LGBTQI+ community, healthcare workers, and the general public). | Communications Medicine

Fig. 4: Global map showing the regional pooled prevalence of mpox vaccine uptake across five population groups (overall, PLHIV, LGBTQI+ community, healthcare workers, and the general public).

From: Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis

Fig. 4

a Population-wide (overall) rates of uptake of the mpox vaccine across all six WHO global regions. b Rates of uptake of the mpox vaccine among the accepting group according to WHO global regions (using data available for only three regions: AMR, EUR, and WPR). c Rates of uptake of the mpox vaccine among PLHIV according to WHO global regions (using data available for only three regions: AMR, EUR, and WPR). d Rates of uptake of the mpox vaccine among the LGBTQI+ community according to WHO global regions (using data available for only three regions: AMR, EUR, and WPR). e Rates of uptake of the mpox vaccine among the general public according to WHO global regions (using data available for only three regions: AFR, AMR, and EUR). Darker areas indicate higher rates, and lighter areas indicate lower rates. Maps adapted from OpenStreetMap under a Creative Commons licence CC BY-SA 2.0.

Back to article page